Table 2 Baseline, disease, and treatment characteristics of the two groups.
Good responders (Group 1, n = 15) | Poor responders (Group 2, n = 15) | p | |
|---|---|---|---|
Age/years (mean ± SD) | 55.06 ± 12.89 | 53.73 ± 9.62 | 0.75 |
Male (n) | 11 | 10 | 0.69 |
Female (n) | 4 | 5 | 0.69 |
Hypertension (n) | 7 | 6 | 0.71 |
Diabetes (n) | 3 | 2 | 0.62 |
Disease duration/months (mean, min–max) | 54.73 (4–80) | 52.2 (4–166) | 0.35 |
Recurrent form (n) | 10 | 10 | 0.99 |
Baseline visual acuity ETDRS letters (mean ± SD) | 76 ± 14.04 | 69.26 ± 9.39 | 0.13 |
Baseline CSMT (µm) | 362.6 ± 71.60 | 355.67 ± 106.51 | 0.85 |
Treatment duration (months) (mean, min–max) | 4.2 (3–12) | 5.53 (3–12) | 0.19 |
